We don't know. It may be a normal update, with man
Post# of 72440
Or there may be some kind of clinical trial update. But the fact that they want questions in advance says to me that this is just an ordinary, good shareholder-relations thing.
Please remember that bashers want to set up huge expectations, then when there isn't some huge news, they use that as an excuse to pound the stock. So don't fall into their trap -- let's just wait and see, and not build up huge expectations.
By the way I applaud their decision to require questions in advance. Just think of the level of discourse we've seen at lieHUB. Imagine having some of those people pipe up with BS -- there's no good way to handle disruptive, dishonest "questioners" that does anything but give the company a black eye.